- Home
- SSII vs KURA Comparison
SSII vs KURA Comparison
Compare SSII & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SSII | KURA |
|---|---|---|
| Founded | N/A | 2014 |
| Country | India | United States |
| Employees | 378 | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 932.9M | 744.0M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | SSII | KURA |
|---|---|---|
| Price | $4.76 | $8.73 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 10 |
| Target Price | N/A | ★ $26.50 |
| AVG Volume (30 Days) | 67.5K | ★ 1.5M |
| Earning Date | 01-01-0001 | 05-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,482,000.00 |
| Revenue This Year | N/A | $124.03 |
| Revenue Next Year | N/A | $28.63 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 25.24 |
| 52 Week Low | $3.02 | $5.41 |
| 52 Week High | $14.29 | $12.49 |
Technical Indicators
Market Signals| Indicator | SSII | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 51.76 | 50.98 |
| Support Level | $4.31 | $7.99 |
| Resistance Level | $5.13 | $10.50 |
| Average True Range (ATR) | 0.43 | 0.42 |
| MACD | 0.03 | 0.04 |
| Stochastic Oscillator | 58.49 | 53.33 |
Price Performance
Historical ComparisonAbout SSII SS Innovations International Inc.
SS Innovations International Inc is a commercial-stage surgical robotics company focused on transforming patient lives by democratizing access to advanced surgical robotics technologies. The company designs, manufactures, and markets an advanced, next-generation, and affordable surgical robotic system called the SSi Mantra, and the instruments and accessories used with SSi Mantra to perform a wide range of soft-tissue, robotically assisted surgeries. The company earns the majority of its revenue from India.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.